Shilpa Medicare Limited — Important, 17-04-2025: General Updates

Shilpa Medicare Limited has entered into a settlement agreement with Celltrion, Inc. concerning an Arbitral Award issued by the London Court of International Arbitration. Originally facing a financial liability of approximately US$ 3.7 million, the company has negotiated a reduced settlement amount of US$ 3.4 million, which will be paid in installments until July 2025. Importantly, this settlement is not expected to impact the company's future operations or activities, indicating a positive outlook for stakeholders. Investors should continue to monitor any developments related to this settlement, which appears to mitigate a potentially significant financial burden.